Cargando…

MO33-1 Trends in chemotherapy at our hospital and department under the COVID-19 pandemic

Detalles Bibliográficos
Autores principales: Kageyama, Akihiko, Makino, Shinichiro, Ohigashi, An, Tamura, Taichi, Morita, Yuka, Nakamura, Shohei, Yagi, Yu, Kanemasa, Yusuke, Shimoyama, Tatsu, Omuro, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311563/
http://dx.doi.org/10.1016/j.annonc.2021.05.647
_version_ 1783728983133650944
author Kageyama, Akihiko
Makino, Shinichiro
Ohigashi, An
Tamura, Taichi
Morita, Yuka
Nakamura, Shohei
Yagi, Yu
Kanemasa, Yusuke
Shimoyama, Tatsu
Omuro, Yasushi
author_facet Kageyama, Akihiko
Makino, Shinichiro
Ohigashi, An
Tamura, Taichi
Morita, Yuka
Nakamura, Shohei
Yagi, Yu
Kanemasa, Yusuke
Shimoyama, Tatsu
Omuro, Yasushi
author_sort Kageyama, Akihiko
collection PubMed
description
format Online
Article
Text
id pubmed-8311563
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-83115632021-07-26 MO33-1 Trends in chemotherapy at our hospital and department under the COVID-19 pandemic Kageyama, Akihiko Makino, Shinichiro Ohigashi, An Tamura, Taichi Morita, Yuka Nakamura, Shohei Yagi, Yu Kanemasa, Yusuke Shimoyama, Tatsu Omuro, Yasushi Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-07 2021-07-26 /pmc/articles/PMC8311563/ http://dx.doi.org/10.1016/j.annonc.2021.05.647 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Kageyama, Akihiko
Makino, Shinichiro
Ohigashi, An
Tamura, Taichi
Morita, Yuka
Nakamura, Shohei
Yagi, Yu
Kanemasa, Yusuke
Shimoyama, Tatsu
Omuro, Yasushi
MO33-1 Trends in chemotherapy at our hospital and department under the COVID-19 pandemic
title MO33-1 Trends in chemotherapy at our hospital and department under the COVID-19 pandemic
title_full MO33-1 Trends in chemotherapy at our hospital and department under the COVID-19 pandemic
title_fullStr MO33-1 Trends in chemotherapy at our hospital and department under the COVID-19 pandemic
title_full_unstemmed MO33-1 Trends in chemotherapy at our hospital and department under the COVID-19 pandemic
title_short MO33-1 Trends in chemotherapy at our hospital and department under the COVID-19 pandemic
title_sort mo33-1 trends in chemotherapy at our hospital and department under the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311563/
http://dx.doi.org/10.1016/j.annonc.2021.05.647
work_keys_str_mv AT kageyamaakihiko mo331trendsinchemotherapyatourhospitalanddepartmentunderthecovid19pandemic
AT makinoshinichiro mo331trendsinchemotherapyatourhospitalanddepartmentunderthecovid19pandemic
AT ohigashian mo331trendsinchemotherapyatourhospitalanddepartmentunderthecovid19pandemic
AT tamurataichi mo331trendsinchemotherapyatourhospitalanddepartmentunderthecovid19pandemic
AT moritayuka mo331trendsinchemotherapyatourhospitalanddepartmentunderthecovid19pandemic
AT nakamurashohei mo331trendsinchemotherapyatourhospitalanddepartmentunderthecovid19pandemic
AT yagiyu mo331trendsinchemotherapyatourhospitalanddepartmentunderthecovid19pandemic
AT kanemasayusuke mo331trendsinchemotherapyatourhospitalanddepartmentunderthecovid19pandemic
AT shimoyamatatsu mo331trendsinchemotherapyatourhospitalanddepartmentunderthecovid19pandemic
AT omuroyasushi mo331trendsinchemotherapyatourhospitalanddepartmentunderthecovid19pandemic